Company Filing History:
Years Active: 2025
Title: JungHun Lee: Innovator in Hemoglobin Derivatives
Introduction
JungHun Lee is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of biomedical innovations, particularly in the development of blood substitutes.
Latest Patents
One of his key patents is titled "Hemoglobin derivative co-conjugated with fatty acid-linked PEG and alkoxy PEG as a blood substitute." This invention focuses on a hemoglobin derivative that is co-conjugated with both fatty acid-linked polyethylene glycol (FA-PEG) derivatives and alkoxy polyethylene glycol (alkoxy-PEG) derivatives. The method for creating this hemoglobin derivative is also outlined in the patent. Various embodiments include crosslinked hemoglobin that exhibits non-toxicity and an extended intravascular retention time.
Career Highlights
JungHun Lee has worked with several prominent companies, including Sun Bio, Inc. and Samsung Display Co., Ltd. His experience in these organizations has contributed to his expertise in the field of biomedical research and innovation.
Collaborations
He has collaborated with notable coworkers such as Kwang Nho and Minjung Ahn, further enhancing his contributions to the field.
Conclusion
JungHun Lee's innovative work in hemoglobin derivatives showcases his commitment to advancing medical technology. His contributions are significant in the pursuit of effective blood substitutes.